Technology area: Biotechnology & Pharmaceuticals
7 pending office actions • 5 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready • 12 patents granted in the last 365 days
Xiamen University is active in the Biotechnology & Pharmaceuticals technology area, with 8 pending office actions currently under review. These actions are distributed across 8 distinct examiners, meaning that every pending application is being handled by a different individual. This distribution occurs across 6 distinct art units, suggesting that the university's biotech innovations are categorized into several different technical specialties within the patent office.
The workload is perfectly spread among the assigned staff, as the busiest examiner, GROOMS, NOA WILLIAM FRAN, is responsible for only 1 busiest examiner pending action. With 8 distinct examiners each managing a portion of the 8 pending office actions, no single examiner has a dominant influence over the portfolio. The involvement of 6 distinct art units requires the university to navigate the specific guidelines of multiple examination groups while addressing the individual styles of the assigned examiners.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (57%) |
| §112 only | 2 (29%) |
| Multi-statute (no §101) | 1 (14%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| GROOMS, NOA WILLIAM FRAN | 1 | 83.3% | +0.0% |
| VARADARAJ, ARCHANA | 1 | 80.0% | +33.3% |
| AULAKH, CHARANJIT | 1 | 80.7% | -14.5% |
| NIEBAUER, RONALD T | 1 | 40.8% | +34.0% |
| REYNOLDS, FRED H | 1 | 32.9% | +39.3% |
| HOPKINS, DAVID ANDREW | 1 | 32.1% | +37.7% |
| JAUHARI, SACHI | 1 | 60.0% | +80.0% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18544186 | CATALYST, APPLICATION THEREOF, AND METHOD FOR PREPARING 2,5-FURANEDICARBOXYLIC ACID BY CATALYZING 5-HYDROMETHYLFURFURAL IN BASE-FREE CONDITION | AULAKH, CHARANJIT | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18350803 | PEPTIDE DISINFECTANT FOR PREVENTING CORONAVIRUSES | NIEBAUER, RONALD T | 60d |
| 18704949 | LUMINESCENT MATERIAL AND MINI-LED DEVICE PREPARED USING LUMINESCENT MATERIAL | GROOMS, NOA WILLIAM FRAN | — |
| 18398278 | ANTIMICROBIAL PEPTIDE SCYAMPCIN44-63 AND APPLICATION THEREOF | VARADARAJ, ARCHANA | — |
| 18169144 | METHOD OF OPTIMIZING A DESIGN OF A STRUCTURE BY CONSIDERING CENTRIFUGAL LOADS AND STRESS CONSTRAINTS | HOPKINS, DAVID ANDREW | — |
| 18005543 | CELL-PENETRATING PEPTIDE AND USE THEREOF | JAUHARI, SACHI | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18350803 | PEPTIDE DISINFECTANT FOR PREVENTING CORONAVIRUSES | NIEBAUER, RONALD T | 60d |
| 18337091 | PREPAKAGED POLYMERASE CHAIN REACTION (PCR) REAGENT FOR NUCLEIC ACID AMPLIFICATION AND METHOD THEREOF | REYNOLDS, FRED H | 70d |
| 18398278 | ANTIMICROBIAL PEPTIDE SCYAMPCIN44-63 AND APPLICATION THEREOF | VARADARAJ, ARCHANA | — |
| 18169144 | METHOD OF OPTIMIZING A DESIGN OF A STRUCTURE BY CONSIDERING CENTRIFUGAL LOADS AND STRESS CONSTRAINTS | HOPKINS, DAVID ANDREW | — |
| 18005543 | CELL-PENETRATING PEPTIDE AND USE THEREOF | JAUHARI, SACHI | — |
| Art Unit | Apps |
|---|---|
| 1658 | 3 |
| 1734 | 1 |
| 1621 | 1 |
| 2188 | 1 |
| 1654 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18704949 | LUMINESCENT MATERIAL AND MINI-LED DEVICE PREPARED USING LUMINESCENT MATERIAL | GROOMS, NOA WILLIAM FRAN | 1734 | §103§112 | Non-Final OA | — | Pending | Apr 26, 2024 |
| 18398278 | ANTIMICROBIAL PEPTIDE SCYAMPCIN44-63 AND APPLICATION THEREOF | VARADARAJ, ARCHANA | 1658 | §101§102§112 | Non-Final OA | — | Pending | Dec 28, 2023 |
| 18544186 | CATALYST, APPLICATION THEREOF, AND METHOD FOR PREPARING 2,5-FURANEDICARBOXYLIC ACID BY CATALYZING 5-HYDROMETHYLFURFURAL IN BASE-FREE CONDITION | AULAKH, CHARANJIT | 1621 | §112 | Final Rejection | — | Pending | Dec 18, 2023 |
| 18350803 | PEPTIDE DISINFECTANT FOR PREVENTING CORONAVIRUSES | NIEBAUER, RONALD T | 1658 | §101§102§112 | Non-Final OA | 60d | Pending | Jul 12, 2023 |
| 18337091 | PREPAKAGED POLYMERASE CHAIN REACTION (PCR) REAGENT FOR NUCLEIC ACID AMPLIFICATION AND METHOD THEREOF | REYNOLDS, FRED H | 1658 | §112 | Final Rejection | 70d | Pending | Jun 19, 2023 |
| 18169144 | METHOD OF OPTIMIZING A DESIGN OF A STRUCTURE BY CONSIDERING CENTRIFUGAL LOADS AND STRESS CONSTRAINTS | HOPKINS, DAVID ANDREW | 2188 | §101§112 | Final Rejection | — | Pending | Feb 14, 2023 |
| 18005543 | CELL-PENETRATING PEPTIDE AND USE THEREOF | JAUHARI, SACHI | 1654 | §101§112 | Final Rejection | — | Pending | Jan 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialXiamen University has 7 pending office actions as of October 2026, spread across 5 art units and 7 examiners.
Noa William Fran Grooms has the most, with 1 of Xiamen University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
